Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

Postpartum hemorrhage (PPH) remains one of the leading causes of maternal morbidity and mortality worldwide, although the lack of a precise definition precludes accurate data of the absolute prevalence of PPH.

[1]  W. Rath.  Postpartum hemorrhage – update on problems of definitions and diagnosis * , 2011, Acta obstetricia et gynecologica Scandinavica.

[2]  Karim Brohi,et al.  Functional definition and characterization of acute traumatic coagulopathy , 2011, Critical care medicine.

[3]  B. Yawn,et al.  Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. , 2001, American journal of obstetrics and gynecology.

[4]  D. Elbourne,et al.  Prophylactic use of oxytocin in the third stage of labour. , 2001, The Cochrane database of systematic reviews.

[5]  C. Lee,et al.  Pregnancy in women with congenital factor VII deficiency , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  P. Collins,et al.  The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. , 2010, International journal of obstetric anesthesia.

[7]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[8]  A. Weeks,et al.  Active versus expectant management for women in the third stage of labour. , 2015, The Cochrane database of systematic reviews.

[9]  A. H. Rosenthal,et al.  Postpartum hemorrhage. , 1950, American journal of surgery.

[10]  C. Demers,et al.  Gynaecological and obstetric management of women with inherited bleeding disorders , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[11]  E. Myers,et al.  Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. , 2006, American journal of obstetrics and gynecology.

[12]  P. Bucciarelli,et al.  Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage , 2012, Journal of thrombosis and haemostasis : JTH.

[13]  S. Higgins,et al.  Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. , 2004, The Cochrane database of systematic reviews.

[14]  H. V. van Geijn,et al.  Use of recombinant activated factor VII in massive postpartum haemorrhage. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[15]  A. Caruso,et al.  Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa , 1997, Acta obstetricia et gynecologica Scandinavica.

[16]  Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. , 1997, The New England journal of medicine.

[17]  G. Lippi,et al.  The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage , 2006, BJOG : an international journal of obstetrics and gynaecology.

[18]  B. Sibai,et al.  Blood Transfusion and Cesarean Delivery , 2006, Obstetrics and gynecology.

[19]  E. Moore,et al.  Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. , 2009, Surgery.

[20]  P. Kamphuisen,et al.  Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. , 2009, American journal of obstetrics and gynecology.

[21]  R. Kaufman,et al.  Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage , 2009, Transfusion.

[22]  T. Ikenoue,et al.  Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan , 2011, International Journal of Hematology.

[23]  F. Althabe,et al.  Risk Factors for Postpartum Hemorrhage in Vaginal Deliveries in a Latin-American Population , 2009, Obstetrics and gynecology.

[24]  Kenichi A. Tanaka,et al.  Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding , 2012, Anesthesia and analgesia.

[25]  Prevention and Management of Postpartum Haemorrhage , 2000 .

[26]  A. Sauaia,et al.  Primary Fibrinolysis Is Integral in the Pathogenesis of the Acute Coagulopathy of Trauma , 2010, Annals of surgery.

[27]  S. Susen,et al.  High-dose tranexamic acid reduces blood loss in postpartum haemorrhage , 2011, Critical care.

[28]  R. Kalil,et al.  Factor X deficiency and pregnancy: case report and counselling , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[29]  E. Samain,et al.  The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage , 2007, Journal of thrombosis and haemostasis : JTH.

[30]  C. Combs,et al.  Factors Associated With Hemorrhage in Cesarean Deliveries , 1991, Obstetrics and gynecology.

[31]  P. Peitsidis,et al.  Bernard Soulier syndrome in pregnancy: a systematic review , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[32]  B. Cotton,et al.  Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. , 2009, The Journal of trauma.

[33]  P. Sandset,et al.  Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. , 2008, American journal of obstetrics and gynecology.

[34]  M. Laffan,et al.  Use of recombinant activated factor VII in massive obstetric haemorrhage. , 2007, International journal of obstetric anesthesia.

[35]  N. Sebire,et al.  The risks associated with pregnancy in women aged 35 years or older. , 2000, Human reproduction.

[36]  C. C. Roby,et al.  Coagulation defects associated with premature separation of the normally implanted placenta. , 1950, American journal of obstetrics and gynecology.

[37]  B. Ramsahoye,et al.  Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a reivesw of the literature , 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

[38]  G. Greenberg,et al.  Drugs in Pregnancy and Lactation , 1990 .

[39]  B. Faltas,et al.  Update on perioperative bridging in patients on chronic oral anticoagulation , 2009, Expert review of cardiovascular therapy.

[40]  T. Goodwin,et al.  Congenital hypofibrinogenemia in pregnancy. , 1989, Obstetrical & gynecological survey.

[41]  G. Bonsel,et al.  Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[42]  K. Inaba,et al.  FIBTEM provides early prediction of massive transfusion in trauma , 2011, Critical care.

[43]  A. Tosetto,et al.  Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation , 2011, Journal of thrombosis and haemostasis : JTH.

[44]  Y. Oyelese.  Postpartum Hemorrhage: Epidemiology, Risk Factors, and Causes , 2010, Clinical obstetrics and gynecology.

[45]  G. Dekker,et al.  Recommendations for the prevention of pregnancy‐associated venous thromboembolism , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.

[46]  Contributions from M. Walpole.  The Millennium Development Goals Report , 2008 .

[47]  P. Cameron,et al.  Recombinant Activated Factor VII in Obstetric Hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry , 2009, Anesthesia and analgesia.

[48]  J. Ray,et al.  Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. , 2000, Obstetrical & gynecological survey.

[49]  B. Coller,et al.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders , 2010, Journal of thrombosis and haemostasis : JTH.

[50]  A. Mumford,et al.  A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[51]  B. Brenner.  Haemostatic changes in pregnancy. , 2004, Thrombosis research.

[52]  R. Kadir,et al.  Management of pregnancy, labour and delivery in women with inherited bleeding disorders , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[53]  A. McDonald,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.

[54]  V. Rodriguez,et al.  Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh‐frozen plasma , 2009, Transfusion.

[55]  E. Triche,et al.  Use of recombinant activated factor VII for massive postpartum hemorrhage , 2007, Acta obstetricia et gynecologica Scandinavica.

[56]  J. Tolosa,et al.  Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. , 2013, The Cochrane database of systematic reviews.

[57]  S. Singh,et al.  A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS) * , 2012, Anaesthesia.

[58]  B. Seifert,et al.  Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. , 2011, British journal of anaesthesia.

[59]  A. James,et al.  Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease , 2007, Journal of thrombosis and haemostasis : JTH.

[60]  D. Economides,et al.  Pregnancy in women with von Willebrand's disease or factor XI deficiency , 1998, British journal of obstetrics and gynaecology.

[61]  P. Collins,et al.  Fibrinogen concentrate use during major obstetric haemorrhage , 2010, Anaesthesia.

[62]  P. James,et al.  Generation and validation of the Condensed MCMDM‐1VWD Bleeding Questionnaire for von Willebrand disease , 2008, Journal of thrombosis and haemostasis : JTH.

[63]  W. Ouwehand,et al.  Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia , 2001, British journal of haematology.

[64]  C. Hofer,et al.  Thrombelastography in the surgical patient. , 2010, Minerva anestesiologica.

[65]  Christine A. Lee,et al.  Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[66]  C. Paterson,et al.  Risk factors for major obstetric haemorrhage. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[67]  W. Henrich,et al.  Diagnosis and treatment of peripartum bleeding , 2008, Journal of perinatal medicine.

[68]  K. Salvesen,et al.  Use of Recombinant Activated Factor VII in Primary Postpartum Hemorrhage: The Northern European Registry 2000–2004 , 2007, Obstetrics and gynecology.

[69]  C. Lee,et al.  Is primary postpartum haemorrhage a good predictor of inherited bleeding disorders? , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[70]  M. Berman,et al.  The Epidemiology of Postpartum Hemorrhage in a Large, Nationwide Sample of Deliveries , 2010, Anesthesia and analgesia.

[71]  D. Economides,et al.  The obstetric experience of carriers of haemophilia. , 1998, British journal of obstetrics and gynaecology.

[72]  J. Michalek,et al.  Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients , 2008, Annals of surgery.

[73]  C. Wade,et al.  The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. , 2007, The Journal of trauma.

[74]  S. Yentis.  Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions , 2006, BJOG : an international journal of obstetrics and gynaecology.

[75]  F. Peyvandi,et al.  Post-partum hemorrhage in women with rare bleeding disorders. , 2011, Thrombosis research.

[76]  B. Stray-Pedersen,et al.  Prevalence and risk factors of severe obstetric haemorrhage , 2008, BJOG : an international journal of obstetrics and gynaecology.

[77]  S. Watson,et al.  A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO , 2006, British journal of haematology.

[78]  J. Ingerslev,et al.  Fibrinogen concentrate – a potential universal hemostatic agent , 2009, Expert opinion on biological therapy.

[79]  C. Deneux-Tharaux,et al.  Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case–control study , 2011, BMJ Open.

[80]  Matthew Joslin,et al.  Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries , 2010, BMJ : British Medical Journal.

[81]  G. Lowe,et al.  Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies , 1991, British journal of obstetrics and gynaecology.

[82]  C. Colin,et al.  Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. , 2012, British journal of anaesthesia.